Medikit Co.,Ltd

Short Term Long Term Short Term Comparison Long Term Comparison

7749
1d0.00%
1w-1.05%
1m0.00%
1y7.01%
7749
1y7.01%
5y-9.31%
10y-22.29%
20y0.00%

Bitcoin
4.06%
28.35%
16.79%
-32.80%
Bitcoin
-32.80%
228.23%
49,001.40%
0.00%

Ethereum
-0.06%
12.89%
6.70%
-39.16%
Ethereum
-39.16%
223.01%
0.00%
0.00%

Gold
0.09%
5.02%
8.57%
4.12%
Gold
4.12%
53.13%
24.90%
503.09%

Silver
1.22%
4.32%
4.25%
-9.23%
Silver
-9.23%
40.47%
-21.11%
414.95%

Apple
-0.55%
3.01%
1.61%
-4.90%
Apple
-4.90%
271.12%
-65.71%
68,272.30%

Amazon
-1.09%
7.05%
1.80%
-38.64%
Amazon
-38.64%
24.74%
-61.54%
7,109.47%

Microsoft
1.17%
10.05%
8.28%
-6.08%
Microsoft
-6.08%
217.92%
886.86%
1,599.88%

S&P 500
-1.10%
1.58%
-3.98%
-12.24%
S&P 500
-12.24%
44.16%
151.27%
347.27%

Dow & Jones
-1.19%
0.13%
-5.81%
-8.32%
Dow & Jones
-8.32%
28.85%
119.56%
284.50%

ATH

ATH Price$3,813.66
ATH Date2020-01-15
% since ATH-36.02%
% to ATH56.30%

ATL

ATL Price$253.42
ATL Date2008-01-28
% from ATL862.83%
Last Low Price$2139.48
Last Low Date2022-05-23
% From Last Low14.05%

IPO

IPO Price$65,100.00
% Current ROI USD-96.25%
ATH Price$3,813.66
% ROI ATH 150,487.73%

Graph takes few seconds to load...

Key Data

Current price	$2440
Sector	Healthcare
Industry	Medical Instruments & Supplies
Today's High/Low	$2440/$2440
Volume	200.00
Previous Close	$2440
52 Week High/Low	$2645/$2113.81
Market Cap	40,939,540,480.00
P/E Ratio	13.9468
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$0
Annualized Dividend	$0.0244

$2440

Medikit Co.,Ltd. engages in the manufacture and sale of vascular access medical devices. The company offers IV catheters, such as supercath 5, supercath Z3V, and supercath Ztu-V for hospitals and emergency services; hemodialysis products, including supercath NEO and supercath CLS; and intervention products comprising Supersheath, Mongoose, and Meito Masamune.
Its products are used in anesthetic departments, operating theaters, ICUs, and dialysis and cardiology units.
The company markets its products through distributors in approximately 20 countries and territories in the European Union and on the American continent. Medikit Co.,Ltd. was founded in 1973 and is headquartered in Tokyo, Japan.

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31
Cash on hand	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	$4,810.12	$4,522.04	$4,291.59	$4,206.69	$4,006	$3,707	$3,591	$3,436	$3,487	$3,463	$3,158	$3,055	$2,909	$2,890	$2,938	$2,747	$2,679	$2,758
Inventory	$3,693.63	$2,858.08	$2,714.71	$2,351.96	$2,294	$2,291	$1,865	$1,765	$1,816	$1,453	$1,579	$1,694	$1,534	$1,288	$1,188	$804	$759	$742
Pre-Paid Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	$106.52	$112.27	$174.33	$308.78	$1,770	$1,755	$298	$298	$448	$328	$323	$296	$324	$297	$250	$228	$273	$272
Total Current Assets	$36,942.98	$34,538.32	$33,142.66	$31,625.95	$30,230	$27,963	$28,999	-	-	-	-	-	-	-	-	-	-	-
Property, Plant, And Equipment	$9,688	$9,251	$8,789	$8,609	$8,620	$8,765	$9,068	$8,290	$8,519	$7,645	$7,745	$7,982	$7,964	$6,605	$6,155	$5,885	$5,245	$5,196
Long-Term Investments	-	$1,021	$1,038	$863	$774	$871	$760	-	-	-	-	-	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Long-Term Assets	$947	$942	$685	$515	$527	$454	$940	$985	$843	$987	$908	$811	$798	$1,016	$1,249	$1,475	$1,714	$1,924
Total Long-Term Assets	$12,080.08	$11,742.38	$11,137.81	$10,626.98	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	$49,023.06	$46,280.71	$44,280.47	$42,252.93	$40,243	$38,076	$39,483	$37,006	$35,960	$34,084	$32,360	$30,824	$29,600	$28,621	$27,372	$23,994	$22,476	$21,192
Total Current Liabilities	$4,501.80	$3,911.42	$3,795.22	$3,614.42	$3,536	$3,105	$3,516	$2,626	$3,107	$2,828	$2,639	$2,457	$2,423	$2,412	$2,522	$2,896	$2,698	$3,494
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$206	$746	$540
Other Non-Current Liabilities	$2,354	$2,322	$2,338	$2,282	$2,217	$2,009	$2,161	$2,139	$1,953	$1,937	$1,971	$1,908	$1,841	$1,827	$1,805	$1,735	$1,644	$1,523
Total Long Term Liabilities	$2,352.11	$2,320.37	$2,337.08	$2,281.61	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	$6,853.91	$6,231.78	$6,132.30	$5,896.03	$5,753	$5,114	$5,678	$4,765	$5,060	$4,765	$4,610	$4,365	$4,264	$4,239	$4,327	$4,837	$5,088	$5,557
Common Stock Net	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$1,241	$370	$271	$271
Retained Earnings (Accumulated Deficit)	$33,201.43	$31,076.43	$29,135.89	$27,306.55	$25,604	$23,847	$22,202	$20,770	$19,515	$17,950	$16,307	$15,016	$13,876	$12,650	$11,286	$9,506	$7,937	$6,210
Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Share Holders Equity	$91	$95	$135	$173	$9	$238	$173	-	-	-	-	-	-	-	-	-	-	-
Share Holder Equity	$42,169.15	$40,048.92	$38,148.18	$36,356.90	$34,490	$32,962	$33,805	$32,241	$30,900	$29,319	$27,750	$26,459	$25,336	$24,382	$23,045	$19,157	$17,388	$15,635
Total Liabilities And Share Holders Equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31
Revenue	$19,893.20	$18,501.80	$17,445.21	$16,850.58	$15,722	$14,850	$14,529	$13,990	$14,126	$13,779	$12,967	$12,331	$11,926	$11,574	$11,062	$10,339	$10,310	$10,203
Cost Of Goods Sold	$11,572.62	$10,800.30	$10,030.84	$9,707.65	$8,921	$8,346	$7,471	$7,123	$6,851	$6,660	$6,392	$5,946	$5,702	$5,611	$4,907	$4,404	$4,501	$4,330
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Expenses	-	-	$242	$237	$214	$353	$329	$245	$208	$200	$188	$188	$151	$161	$137	$160	-	-
SG&A Expenses	-	$3,604	$3,638	$3,511	$3,084	$2,935	$3,193	$3,050	$2,978	$2,922	$2,877	$2,872	$2,817	$2,688	$2,622	$2,664	$2,706	$2,466
Other Operating Income Or Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	$15,563.79	$14,632.74	$13,810.11	$13,339.16	$12,120	$11,415	$11,386	-	-	-	-	-	-	-	-	-	-	-
Operating Income	$4,329.40	$3,869.06	$3,635.11	$3,511.42	$3,602	$3,435	$3,145	$3,049	$3,668	$3,550	$2,994	$2,653	$2,604	$2,787	$3,094	$2,829	$3,103	$3,407
Total Non-Operating Income/Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	$4,334.96	$3,892.97	$3,717.43	$3,526.90	$3,661	$3,495	$3,235	$3,008	$3,631	$3,594	$2,984	$2,762	$2,999	$3,142	$3,392	$3,195	$3,380	$3,486
Income Taxes	$1,446	$1,316	$1,252	$1,231	$1,354	$1,311	$1,288	$1,178	$1,599	$1,483	$1,225	$1,153	$1,302	$1,332	$1,466	$1,482	$1,591	$1,689
Income After Taxes	$1,446	$1,316	$1,252	$1,231	$1,354	$1,311	$1,288	$1,178	$1,599	$1,483	$1,225	$1,153	$1,302	$1,332	$1,466	$1,482	$1,591	$1,689
Other Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Continuous Operations	$2,887.99	$2,576.37	$2,465.17	$2,295.82	$2,307	$2,184	$1,946	-	-	-	-	-	-	-	-	-	-	-
Income From Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	$2,887.99	$2,576.37	$2,465.17	$2,295.82	$2,307	$2,184	$1,946.26	$1,830.32	$2,031.04	$2,109.03	$1,757.44	$1,607.24	$1,695.50	$1,807.63	$1,906.28	$1,690.03	$1,768.86	$1,322.88
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	$4,329.40	$3,869.06	$3,635.11	$3,511.42	$3,602	$3,435	$3,145	$3,049	$3,668	$3,550	$2,994	$2,653	$2,604	$2,787	$3,094	$2,829	$3,103	$3,407
Basic Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31
Net Income/Loss	$2,887.99	$2,576.37	$2,465.17	$2,295.82	$2,307	$2,184	$1,946.26	$1,830.32	$2,031.04	$2,109.03	$1,757.44	$1,607.24	$1,695.50	$1,807.63	$1,906.28	$1,690.03	$1,768.86	$1,322.88
Total Depreciation And Amortization - Cash Flow	$1,318.56	$1,178.28	$1,014.12	$920.61	$882	$924	$720	-	-	-	-	-	-	-	-	-	-	-
Change In Accounts Receivable	-	$-230	$-84	$-200	$-277	$-113	$-130	$51	-	-	-	-	-	$25	-	-	-	-
Change In Inventories	$-835.55	$-144.23	$-362.75	$-57.44	$-3	$-425	$-99	$50	-	$125	$114	-	-	-	-	-	-	-
Cash Flow From Operating Activities	$3,540.67	$3,796.12	$3,114.41	$2,926.66	$3,288	$2,583	$2,996	$2,528	$2,461	$2,812	$2,730	$2,347	$2,034	$1,607	$1,849	$1,815	$1,986	$2,638
Cash Flow From Investing Activities	$-1,455	$-1,816	$-1,135	$-1,587	$-778	$-1,016	$-1,071	-	-	-	-	-	-	-	-	-	$334	$562
Debt Issuance/Retirement Net - Total	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Common And Preferred Stock Dividends Paid	$-762.89	$-635.81	$-635.76	$-593.23	$-550	$-533	$-514	$-514	$-467	$-467	$-468	$-467	$-471	$-424	$-126	$-124	-	-
Financial Activities - Other	$-1	$-1	$-1	$-1	$-1	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Flow From Financial Activities	-	$-636	$-635	$-593	$-550	$-3,117	$-514	-	-	-	-	-	-	-	$1,137	-	-	-
Net Cash Flow	$1,286.77	$1,323.05	$1,323.15	$739.06	$1,950	$-1,535	$1,432	-	-	-	-	-	-	-	-	-	-	-
Common Stock Dividends Paid	$-762.89	$-635.81	$-635.76	$-593.23	$-550	$-533	$-514	$-514	$-467	$-467	$-468	$-467	$-471	$-424	$-126	$-124	-	-